16 February 2016
IntegraGen’s oncology Scientific Advisory Board (SAB) recently met at the venue of the 2016 American Society of Oncology’s (ASCO) Gastrointestinal Cancers Symposium in San Francisco to review the results from the latest clinical study exploring the predictivity of miR-31-3p on the efficacy of anti-EGFR therapy in all-RAS wild-type metastatic colorectal cancer (…) »
07 January 2016
IntegraGen Genomics will organize an educational luncheon symposium entitled “Exomes et RNASeq : de la recherche à la recherche clinique : challenges et perspectives” during the upcoming 8èmes Assises de Génétique Humaine et Médicale being held in Lyon, France. The program will be held from 12h45 to 13h45 on (…) »
06 November 2015
Florence Pinaud’s interview with IntegraGen CEO Bernard Courtieu as a part of her story on newer genetic sequencing technologies, potential ethical issues associated with genetic sequencing, and the need for advanced data processing in association with these technologies appears (…) »
28 August 2015
Bernard Courtieu, CEO of IntegraGen, is interviewed by EEI – Biotech for Finance. Mr. Courtieu discusses IntegraGen’s role in the sequencing of liver tumors as a part of a recent publication announcing the identification of a new virus involved in the development of liver cancer.
The interview (…) »
05 May 2015
Welcome to the inaugural issue of our newsletter. The goal of IntegraNews is to provide an update on the latest news and events at IntegraGen Genomics. This includes the availability of the latest technologies and molecular testing platforms in our lab and new service offerings.
Click here to download IntegraNews
22 April 2015
Data from two studies reporting results from clinical studies with IntegraGen’s miR-31-3p biomarker is scheduled to be presented during the 51st Annual Meeting of the American Society of Clinical Oncology (ASCO) being held in Chicago on May 29 through June 2, 2015.
The first study will report results from research conducted in cooperation (…) »
18 February 2015
IntegraGen Genomics has announced the launch of GeCo, an advanced genomic consulting service which offers statistical support to help researchers analyze and interpret complex genomic data. IntegraGen will offer researchers access to leading experts in the field of biostatistics and bioanalytics and offer support for the advanced and personalized statistical analysis of genomic (…) »